Filing Flows › Dolby Laboratories (DLB) › Capital expenditures
Dolby Laboratories (DLB) capital expenditures by quarter
Dolby Laboratories' capital expenditures were $15.0M in Q3 FY26 (third quarter fiscal 2026), +65% from Q2 FY26. Over the last 7 quarters it ranged from $4.6M (Q1 FY26) to $16.2M (Q4 FY25).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 FY26 | $15.0M | +65% | +133% |
| Q2 FY26 | $9.1M | +96% | +31% |
| Q1 FY26 | $4.6M | -72% | — |
| Q4 FY25 | $16.2M | +153% | +120% |
| Q3 FY25 | $6.4M | -7% | — |
| Q2 FY25 | $6.9M | -7% | — |
| Q4 FY24 | $7.4M | — | — |
Q3 FY26 at a glance
Dolby Laboratories, Q3 FY26: revenue $305M (-3% year over year), operating margin 11.3%, net earnings $28.6M, operating cash flow $167M. The chart follows the revenue to costs, profit and cash.
Questions
What is Dolby Laboratories' capital expenditures?
Dolby Laboratories' capital expenditures were $15.0M in Q3 FY26 (third quarter fiscal 2026), +65% from Q2 FY26.
How has Dolby Laboratories' capital expenditures changed?
Over the last 7 quarters it ranged from $4.6M (Q1 FY26) to $16.2M (Q4 FY25).